Author: Scott Minnis

21 Mar Commercial Strategies to Optimize Biosimilars Market

Karen Russo  Since the biosimiliars market is still in its infancy stage, biopharmaceutical companies that are attempting to enter the space are encountering a variety of distinct challenges. The global regulations not only remain complicated, but they also continue to evolve and differ across certain regions...

Read More